Orchard Therapeutics and UCLA Receive $20 Million in Latest Round of Funding from California’s Stem Cell Agency
London, UK, November 23, 2016 / B3C newswire / -- Orchard Therapeutics Limited, a clinical-stage biotechnology company, dedicated to bringing transformative gene therapies to patients with serious and life-threatening orphan diseases and researchers from …